Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-110377
Filing Date
2025-11-12
Accepted
2025-11-12 16:14:35
Documents
69
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atxs-20250930x10q.htm   iXBRL 10-Q 1646966
2 EX-10.1 atxs-20250930xex10d1.htm EX-10.1 573820
3 EX-31.1 atxs-20250930xex31d1.htm EX-31.1 11664
4 EX-31.2 atxs-20250930xex31d2.htm EX-31.2 11642
5 EX-32.1 atxs-20250930xex32d1.htm EX-32.1 8931
  Complete submission text file 0001104659-25-110377.txt   7720802

Data Files

Seq Description Document Type Size
6 EX-101.SCH atxs-20250930.xsd EX-101.SCH 44583
7 EX-101.CAL atxs-20250930_cal.xml EX-101.CAL 41800
8 EX-101.DEF atxs-20250930_def.xml EX-101.DEF 200220
9 EX-101.LAB atxs-20250930_lab.xml EX-101.LAB 429622
10 EX-101.PRE atxs-20250930_pre.xml EX-101.PRE 306637
72 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20250930x10q_htm.xml XML 1235944
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 251472896
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)